Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction
Authors:
Open Access
- 30 December 2019
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 12 (4) , 2350-2358
Abstract
The advent of nanomedicine has recently started to innovate the treatment of cardiovascular diseases, in particular myocardial infarction. Although current approaches are very promising, there is still an urgent need for advanced targeting strategies. In this work, the exploitation of macrophage recruitment is proposed as a novel and synergistic approach to improve the addressability of the infarcted myocardium achieved by current peptide-based heart targeting strategies. For this purpose, an acetalated dextran-based nanosystem is designed and successfully functionalized with two different peptides, atrial natriuretic peptide (ANP) and linTT1, which target, respectively, cardiac cells and macrophages associated with atherosclerotic plaques. The biocompatibility of the nanocarrier is screened on both macrophage cell lines and primary macrophages, showing high safety, in particular after functionalization of the nanoparticles’ surface. Furthermore, the system shows higher association versus uptake ratio towards M2-like macrophages (approximately 2-fold and 6-fold increase in murine and human primary M2-like macrophages, respectively, compared to M1-like). Overall, the results demonstrate that the nanosystem has potential to exploit the “hitchhike” effect on M2-like macrophages and potentially improve, in a dual targeting strategy, the ability of the ANP peptide to target infarcted heart.Keywords
Funding Information
- Helsingin Yliopisto
- Sigrid Juséliuksen Säätiö
- Terveyden Tutkimuksen Toimikunta (317042)
- European Regional Development Fund (2014-2020.4.01.15-0012)
- H2020 European Research Council
This publication has 72 references indexed in Scilit:
- Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticlesBiomaterials, 2012
- Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horseCancer Nanotechnology, 2012
- Effect of interparticle interactions on size determination of zirconia and silica based systems – A comparison of SAXS, DLS, BET, XRD and TEMChemical Physics Letters, 2012
- Acid-Degradable Cationic Dextran Particles for the Delivery of siRNA TherapeuticsBioconjugate Chemistry, 2011
- Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient miceProceedings of the National Academy of Sciences, 2011
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticlesNature Medicine, 2010
- Acetal‐Modified Dextran Microparticles with Controlled Degradation Kinetics and Surface Functionality for Gene Delivery in Phagocytic and Non‐Phagocytic CellsAdvanced Materials, 2010
- Acetal-Derivatized Dextran: An Acid-Responsive Biodegradable Material for Therapeutic ApplicationsJournal of the American Chemical Society, 2008
- The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functionsJournal of Experimental Medicine, 2007
- Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase‐driven uptakeBritish Journal of Pharmacology, 2007